GM GMAN, I am not in BMSN at this time but am waiting to receive additional information from the FDA or BMSN about the status of their IND application. I do follow the stock from time to time though.
It would really be awesome if BMSN were able to successfully exit P2 clinical trial as their business model doesn't take the studies beyond P2. Upon successful completion of P2, they would divest HemaXellerate to a bigger pharma.
Let me split from the board now, just stopped in to respond to a poster that was civil in their response.
Best,
Market Data 
Markets 
AI
